Discover Your Unique Identity

Developing Better Vaccines and Antibody Therapies

Improving the process of identifying the targets of antibodies to develop better treatments.

About Us

What Is Maxitope

Maxitope is a technology developed by our team of researchers at the University of Edinburgh.

The aim of our technology is to improve the success of therapeutic antibodies and vaccines to make better treatments available:



The Problem

Identifying the precise target for antibodies or the ideal vaccine is a challenging problem due to the ensemble of complex three-dimensional shapes that proteins adopt. Many potential therapeutic antibodies and vaccines fail because they do not bind their targets optimally.



Our Mission

By leveraging cutting edge protein thermodynamic modelling we improve the process of identifying the targets of antibodies and designing and developing better antibody treatments, reagents and vaccines.

Our Technology

Making Better Treatments

Contact Us



Cost-Effective

Our technology reduces development costs.



Time-Efficient

Our technology speeds development and speeds the process of securing IP.



Better Quality

Our technology allows for better molecules in development pipelines.



Flexible

Our technology is flexible and can be incorporated into existing discovery pipelines.



Diverse Applications

Our technology can be used by companies working in diverse areas (cancer, autoimmune disease, infectious disease, etc.)



Rationale Design

Our technology allows for rationale design of better vaccines for human and animal health problems.

Who It’s For

Maxitope Technology Applications

Our innovative new technology has a wide variety of potential uses in many different sectors. Some of the companies who will benefit from this technology include: